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Merkel cell carcinoma represents a highly aggressive cutaneous
malignancy characterized by regional recurrences, lymph node
metastases, distant metastases, and high mortality. As the cyto-
morphology of Merkel cell carcinoma can be mimicked by other
malignancies, especially lymphoma and pulmonary small cell
carcinoma, immunocytochemistry is often useful in confirming
the diagnosis. Cell blocks, which are traditionally utilized for
immunocytochemistry, occasionally exhibit insufficient cellular-
ity. Hence, we prospectively investigated the application of
CK20 immunocytochemistry to air-dried, unstained direct smears
in the diagnosis of Merkel cell carcinoma fine needle aspirates
(FNAs). Eight consecutive FNAs of Merkel cell carcinoma were
prospectively examined in this series; seven (88%) cases exhib-
ited immunoreactivity for CK20 in the tumor cells. The one
CK20-negative Merkel cell carcinoma was immunoreactive for
synaptophysin and CD56. This immunophenotype was identical
to that of the original primary tumor. For comparison, air-dried
direct smears prepared from three pulmonary small cell carci-
noma FNAs were examined by CK20 immunocytochemistry.
In all cases, no CK20 immunoreactivity was seen in any of the
tumor cells. In conclusion, direct smears represent a feasible
and robust source of cellular material for immunocytochemical
studies to diagnose Merkel cell carcinoma. This methodology
allows the cytologist to confirm on site that material for diag-
nostic immunocytochemistry is present thereby serving as a safe-
guard in instances where insufficient cell block cellularity is
anticipated or encountered. Diagn. Cytopathol. 2013;41:729–
733. ' 2011 Wiley Periodicals, Inc.
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Merkel cell carcinoma represents a highly aggressive pri-
mary cutaneous neuroendocrine malignancy. Although
Merkel cell carcinoma is a rare entity, the incidence of this
cancer has been increasing steadily.1,2 These tumors are char-
acterized by a high incidence of local recurrences, lymph
node and distant metastases, and high mortality.1 The exact
etiology is unknown; nonetheless, risk factors include
increased age, immunosuppression, and skin radiation expo-
sure.1 Recently, the possibility of a viral etiology has been
raised as a new polyomavirus, Merkel cell polyomavirus, was
characterized from Merkel cell carcinoma tumor tissues.3–5
Fine-needle aspiration (FNA) represents a minimally
invasive technique and an accurate, safe, affordable
means to achieve a tissue diagnosis of metastatic Merkel
cell carcinoma.6–10 An early definitive diagnosis of meta-
static Merkel cell carcinoma allows for accurate staging
and prompt, appropriate management including surgical
removal and/or chemotherapy. The cytomorphology of
Merkel cell carcinoma is typically characterized by small,
round to oval cells with scant cytoplasm and nuclei
exhibiting finely granular chromatin without prominent
nucleoli.7,9,11 The cells can be present as a discohesive
population or as cohesive clusters of cells. In the latter
scenario, nuclear molding is common and rosettes can
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occasionally be observed. Regardless, these cytomorpho-
logic patterns are not specific for Merkel cell carcinoma
as other malignancies such as lymphoma, small cell carci-
noma of the lung, and melanoma can mimic one or both
of these patterns.
Immunohistochemistry serves as a useful ancillary tech-
nique in differentiating Merkel cell carcinoma from morpho-
logically similar malignancies. Nonetheless, there exist only
a limited number of reports in the literature that specifically
examine the role of immunocytochemistry in the diagnosis
of Merkel cell carcinoma in cytology specimens. For
instance, unlike lymphomas, Merkel cell carcinoma is nega-
tive for leukocyte common antigen (LCA) and immuno-
staining with antibodies directed against broad spectrum
cytokeratins characteristically highlight the tumor cells in a
perinuclear dot-like pattern.7 Neuroendocrine differentiation
can be confirmed by demonstrating immunoreactivity of
the tumor cells for one or more of the following markers:
neuron-specific enolase (NSE); CD56; chromogranin; and
synaptophysin. Nonetheless, this overall immunophenotype
does not allow for the distinction between Merkel cell carci-
noma and pulmonary small cell carcinoma.
Immunocytochemistry utilizing antibodies directed
against cytokeratin 7 (CK7) and cytokeratin 20 (CK20)
often allows for the distinction between Merkel cell carci-
noma and pulmonary small cell carcinoma. Whereas the
majority of small cell carcinomas of the lung display
CK7 positivity, only a small subset of Merkel cell carci-
nomas are CK7 positive.12 In contrast, the vast majority
of Merkel cell carcinomas display immunoreactivity
for CK20 whereas pulmonary small cell carcinomas are
essentially CK20 negative.12,13
Ancillary immunocytochemical studies routinely employ
cell blocks prepared from Merkel cell carcinoma FNAs.
Occasionally, insufficient cellularity of the cell blocks can
represent a problematic issue thereby impeding immunophe-
notypic characterization of the tumor cells. This can result
in repeat procedures to obtain additional cellular material
for the cell block, which are not without potential complica-
tions, and can result in delays in treatment. We recently
reported the diagnostic utility of immunocytochemistry on
direct smears in the subclassification of pulmonary non-
small cell carcinomas and the diagnosis of metastatic
melanomas.14,15 Hence, we prospectively investigated the
application of immunocytochemistry for CK20 to cytologic
direct smears prepared from Merkel cell carcinoma FNAs
and describe our experience herein.
Materials and Methods
The study was approved by the Institutional Review
Board at University of Michigan. Eight consecutive cases
of metastatic Merkel cell carcinoma were prospectively
evaluated in which unstained direct smears were prepared,
using positively charged slides, for confirmatory immuno-
cytochemistry. Immunocytochemistry was performed on
air-dried, unstained direct smears, following formalin fixa-
tion, using the Ventana Autostainer (Ventana Medical
Systems, Tucson, AZ) as performed previously.14,15
Immunostaining for CK20 (clone Ks20.8; 1:100 dilution;
Dako, Carpenteria, CA) was performed after protease 2
pretreatment (Ventana Medical Systems, Tucson, AZ) for
8 min. Immunocytochemistry for CD56 (clone 123C3;
predilute; Cell Marque, Rocklin, CA) and synaptophysin
(clone SP11; predilute; Ventana Medical Systems, Tuc-
son, AZ) were performed following 30-min pretreatment
in CC1 buffer at 958C. Finally, immunocytochemistry
for CK20 was applied to direct smears in three cases of
pulmonary small cell carcinoma.
Results
Eight consecutive cases of Merkel cell carcinoma, in
which unstained, air-dried direct smears were obtained
on-site, were analyzed by immunocytochemistry for
CK20. The sites of the FNA procedures and the CK20
immunophenotypes are summarized in Table I. The aspi-
rates in each case were cellular and composed of a dis-
cohesive and/or loosely cohesive population of small,
round blue cells exhibiting nuclei with finely granular
chromatin and high nuclear-to-cytoplasmic ratios (Figs. 1
and 2). In seven (88%) of the eight cases, immunoreactiv-
ity for CK20 was observed (Fig. 1). In one case (Table I;
Case 3), none of the tumor cells were CK20 positive (Fig.
2). The tumor cells were diffusely immunopositive for
the neuroendocrine markers, CD56 and synaptophysin.
This CK20(-)/CD56(+)/synaptophysin(+) immunopheno-
type was identical to that observed in the tumor cells
within the primary site (Fig. 2). For comparison, immuno-
cytochemistry for CK20 was applied to direct smears
prepared from three FNA cases of pulmonary small cell
carcinoma, a morphologic mimic of Merkel cell carci-
noma. In all three cases, the tumor cells did not exhibit
immunoreactivity for CK20.
Discussion
Metastatic Merkel cell carcinoma typically presents cyto-
morphologically as a discohesive, loosely cohesive, and/
Table I. Immunocytochemistry on Direct Smears of Merkel Cell
Carcinoma
Case no. FNA site CK20 immunophenotype
1 Right preauricular nodule Positive
2 Anterior neck lymph node Positive
3 Left postauricular mass Negative
4 Right dorsal foot mass Positive
5 Right axillary lymph node Positive
6 Left submental lymph node Positive
7 Left inguinal nodule Positive
8 Right proximal foot nodule Positive
Abbreviations: CK20, cytokeratin 20; FNA, fine needle aspiration.
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or cohesive population of small round blue cells in FNA
specimens. As these patterns can mimic lymphoma and
especially small cell carcinoma of the lung, difficulties
can be encountered in the cytodiagnosis of metastatic
Merkel cell carcinoma. Accurate diagnosis of this entity
allows for efficacious staging of patients afflicted by this
disease allowing for prompt formulation of appropriate
next steps in management.
An established history of Merkel cell carcinoma is
often helpful and immunocytochemistry serves as an
essential adjunct in confirming the diagnosis and distin-
guishing this tumor from pulmonary small cell carcinoma.
Cell blocks, traditionally, have represented the primary
platform for immunocytochemistry. Nonetheless, insuffi-
ciencies in cellular material are occasionally encountered
in these preparations thereby posing a problematic issue
with regards to further workup of Merkel cell carcinoma
FNAs. Furthermore, the cellularity of the cell blocks, as
determined by examining H&E sections prepared after
processing and embedding, is not immediately known.
Cell block cellularity is influenced by several variables
including: the overall cellularity and percent tumor cellu-
larity of the targeted lesion; the precision in targeting the
lesion in successive FNA passes; effective sampling dur-
ing dedicated passes for the cell block; and handling of
the needle rinse specimen in the cytopreparative labora-
Fig. 1. Immunocytochemistry of a CK20-positive Merkel cell carcinoma. (A) The Diff-Quik and (B) Papanicolaou stained smears demonstrate the pres-
ence of small round blue cells exhibiting nuclei with finely granular chromatin and scant cytoplasm. Nuclear molding can be appreciated on the Diff-
Quik stained slide. (31,000) (C) The malignant cells exhibit immunoreactivity for CK20 in a perinuclear dot-like pattern (31,000). [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Fig. 2. Immunocytochemistry of a CK20-negative Merkel cell carcinoma. (A) A predominantly discohesive population of small round blue cells with
nuclei exhibiting finely granular chromatin is seen in this Diff-Quik stained smear (31,000). (B–D) Immunostains for CK20, CD56, and synaptophysin
are shown, respectively (31,000). The tumor cells are CK20-negative but are positive for CD56 and synaptophysin. (E) The cutaneous primary Merkel
cell carcinoma is displayed (H&E, 3400). (F–H) Immunostains for CK20, CD56, and synaptophysin, respectively, reveal that the tumor cells display
the identical immunophenotype as those demonstrated on the cytologic direct smears (31,000). [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
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tory. Dedicated passes for the needle rinse are often per-
formed to increase the probability that the cell block
exhibits adequate tumor cellularity for ancillary studies.
Nonetheless, it is not possible to ensure the effectiveness
of this approach at the time of the FNA procedure. On
the basis of our experience, we recognized the realistic
possibility that cell blocks can occasionally provide inad-
equate material especially in scenarios where the need for
ancillary studies is the greatest. Hence, we sought to
investigate the application and diagnostic utility of immu-
nocytochemistry using direct smears prepared from FNAs
of metastatic Merkel cell carcinoma.
In this study, we prospectively performed immunocyto-
chemistry for CK20 using unstained, air-dried direct
smears in eight consecutive FNAs performed on patients
with either clinically suspected or previously biopsy-pro-
ven Merkel cell carcinoma. In seven (88%) of these cases,
the tumor cells exhibited immunoreactivity for CK20. In
one case, the CK20 immunostain was negative in the
tumor cells. The previously biopsied cutaneous primary
tumor was reviewed in this case and the CK20 immuno-
phenotype was compared. The CK20(-) immunophenotype
was also observed in the primary tumor. Workup of the
primary tumor biopsy revealed immunoreactivity for the
neuroendocrine markers, CD56, and synaptophysin. Thus,
in this instance, we also performed immunocytochemistry
for these two markers on unstained direct smears. The
CD56 and synaptophysin immunostains were positive in
the FNA specimen reflecting the identical immunopheno-
type in the biopsy specimen. As patients with Merkel cell
carcinoma typically have had tissue biopsy performed
from the primary tumor, this case illustrates the impor-
tance of correlating the cytomorphology and immunophe-
notypes of the primary site and metastatic focus.
Although a limited number of cases were examined in
this study, owing to the rarity of the disease and the pro-
spective manner in which the cases were examined, the
CK20 positivity rate of 88% is in keeping with prior
reports that have specifically analyzed this marker in Mer-
kel cell carcinomas.12,13 Of note, a small number of Mer-
kel cell carcinomas that are immunoreactive for CK7
have been reported in the literature.12,13,16,17 Immunocyto-
chemistry for CK7, however, would be of limited utility
as CK7 positivity would confirm the diagnosis of a
carcinoma but not allow for distinction from small cell
carcinoma of the lung. In this context, demonstrating
nuclear immunoreactivity for TTF-1 would serve an im-
portant role in confirming the diagnosis of pulmonary
small cell carcinoma. In this study, we focused on CK20
immunocytochemistry due to the high specificity of
this marker in the diagnosis of Merkel cell carcinoma.
The specificity of CK20 expression in Merkel cell
carcinoma is highlighted by our observation of the CK20
negative immunophenotype observed on immunostained
direct smears prepared from FNAs of pulmonary small
cell carcinoma.
These findings corroborate our previous reports describ-
ing the efficacy of performing confirmatory immunocyto-
chemistry on air-dried, unstained direct smears.14,15 The
advantage of this approach is mainly 2-fold. First, addi-
tional unstained direct smears on positively charged slides
can be prepared from a given FNA pass, in addition to
the routine Diff-Quik stained and alcohol-fixed Papanico-
laou stained smears, simply by distributing the FNA
material over multiple slides. This would allow for the
cytologist to confirm, during the on-site procedure, that
adequate material has been obtained not only for cyto-
morphologic evaluation but also for ancillary studies.
Specifically, visualization of tumor cells on the Diff-Quik
stained smear would signify the presence of tumor cells
in the additional unstained direct smears. Second, the
unstained smears can be directly and promptly submitted
for immunostaining. In each of these eight cases of meta-
static Merkel cell carcinoma, a final diagnosis inclusive of
the results of confirmatory immunostains was reported on
the same day of the procedure. Hence, this approach can
lead to improved turnaround time in diagnosis.
In addition to unstained direct smears, unstained cyto-
spin preparations also represent an analogous platform for
immunocytochemistry that is especially useful when
encountering limited material on FNAs. The use of cyto-
spins also allows for dispersal of cellular material over
multiple slides thereby enabling the use of panels of
immunostains.18 The efficacy of cytospin preparations in
performing immunocytochemistry is dependent on the
cellularity of the needle-rinse. Immunostaining of smears
and cytospins can both be occasionally associated with
relatively higher background staining. This can pose
challenges in the interpretation of some immunostains,
especially those geared toward immunophenotypic confir-
mation of clonality in lymphoproliferative disorders,
which represent mimics of Merkel cell carcinoma. The
needle-rinse specimen, therefore, remains an integral com-
ponent of FNA specimen triage as a portion of or the
entire needle-rinse can be submitted for flow cytometric
analysis in the diagnostic workup of lymphomas.
We acknowledge that continued utilization of needle
rinses and dedicated passes for the cell block are essential
to preserve the remainder of the cellular material in for-
malin-fixed, paraffin-embedded form for additional future
studies as needed. The use of unstained direct smears for
ancillary immunocytochemistry, however, would reduce
and potentially eliminate the sole reliance on the cell
block for immunocytochemistry. This has important
implications in the optimal triage of FNA material espe-
cially in an era during which the number of ancillary
immunocytochemical and molecular studies to be per-
formed using cytology specimens is likely to increase.
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For instance, the use of FNA material to detect BRAF
mutations in metastatic melanoma along with EGFR and
KRAS mutations in pulmonary non-small cell carcinoma
is becoming increasingly appreciated.14,19,20 In these set-
tings, we have demonstrated that direct smears represent a
robust source of cellular material for the performance of
these molecular studies. Hence, optimization of FNA
specimen triage during on-site assessments represents an
important opportunity for cytopathologists to meet this
challenge. This would further cement the essential role of
FNA cytology in the management of patients with meta-
static cancer while preventing additional invasive proce-
dures that could result from scenarios in which the cell
blocks exhibit insufficient cellularity.
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